We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+10.34%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$924M
AUM Growth
+$150M
Cap. Flow
+$83.1M
Cap. Flow %
9%
Top 10 Hldgs %
69.15%
Holding
144
New
67
Increased
12
Reduced
17
Closed
34

Top Sells

Rank Stock Value
1
BIRK icon
Birkenstock
BIRK
+$10.9M
2
ARES icon
Ares Management
ARES
+$10M
3
DELL icon
Dell
DELL
+$8.27M
4
AMD icon
Advanced Micro Devices
AMD
+$7.3M
5
KVUE icon
Kenvue
KVUE
+$6.91M

Sector Composition

Rank Sector Weight
1 Healthcare 10.29%
2 Industrials 6.39%
3 Consumer Discretionary 2.95%
4 Real Estate 2.77%
5 Technology 2.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBIO
51
Zenas BioPharma
ZBIO
$2.01B
$2.54M 0.27%
+150,000
New +$2.7M
MLTX icon
52
MoonLake Immunotherapeutics
MLTX
$1.46B
$2.52M 0.27%
50,000
GRDN
53
Guardian Pharmacy Services
GRDN
$2.65B
$2.52M 0.27%
+150,000
New +$2.53M
FUN icon
54
Cedar Fair
FUN
$1.69B
$2.42M 0.26%
+60,000
New +$2.74M
HLI icon
55
Houlihan Lokey
HLI
$8.56B
$2.37M 0.26%
+15,000
New +$2.24M
AUR icon
56
Aurora
AUR
$13.6B
$2.37M 0.26%
+400,000
New +$1.67M
RLAY icon
57
Relay Therapeutics
RLAY
$4.42B
$2.27M 0.25%
+320,000
New +$2.39M
CON
58
Concentra Group Holdings
CON
$4.27B
$2.25M 0.24%
+100,496
New +$2.32M
IBTA icon
59
Ibotta
IBTA
$715M
$2.17M 0.24%
+35,284
New +$2.14M
WVE icon
60
Wave Life Sciences
WVE
$1.19B
$2.13M 0.23%
+260,000
New +$1.55M
MDXH icon
61
MDxHealth
MDXH
$24.2M
$2.08M 0.23%
+1,000,000
New +$2.72M
LTH icon
62
Life Time Group Holdings
LTH
$9.59B
$2.08M 0.22%
+85,000
New +$1.91M
MC icon
63
Moelis & Co
MC
$4.7B
$2.06M 0.22%
+30,000
New +$1.94M
RITM icon
64
Rithm Capital
RITM
$5.61B
$2.04M 0.22%
+180,000
New +$2.05M
RNAM
65
DELISTED
Avidity Biosciences
RNAM
$2.02M 0.22%
44,000
-6,000
-12% -$260K
EWTX icon
66
Edgewise Therapeutics
EWTX
$4.74B
$2M 0.22%
+75,000
New +$1.49M
BIOA
67
BioAge Labs
BIOA
$522M
$1.98M 0.21%
+95,000
New +$1.9M
GPGI
68
GPGI Inc
GPGI
$4.13B
$1.96M 0.21%
168,560
-204,680
-55% -$1.73M
AROC icon
69
Archrock
AROC
$5.77B
$1.92M 0.21%
+95,000
New +$1.92M
MGTX icon
70
MeiraGTx Holdings
MGTX
$1.21B
$1.88M 0.2%
+450,492
New +$1.95M
HPE icon
71
Hewlett Packard
HPE
$73.2B
$1.84M 0.2%
+90,000
New +$1.72M
BKV
72
BKV Corp
BKV
$2.77B
$1.83M 0.2%
+100,000
New +$1.81M
REVG
73
DELISTED
REV Group
REVG
$1.82M 0.2%
65,000
ACHR icon
74
Archer Aviation
ACHR
$4.75B
$1.82M 0.2%
+600,000
New +$2.29M
XNCR icon
75
Xencor
XNCR
$1.56B
$1.61M 0.17%
+80,000
New +$1.5M

Similar funds

Monashee Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, Monashee Investment Management held 144 positions worth $924M, up 19% from $773M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Monashee Investment Management deployed $83.1M of net new capital in Q3 2024, opening 67 new positions and adding to 12 existing holdings. Its largest new stake was Casella Waste Systems: 135,000 shares worth $13.4M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, up from 6.6% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Corebridge Financial, an estimated $3.86M trimmed.

  • Monashee Investment Management's largest Q3 2024 buy was Casella Waste Systems: 135,000 shares worth $13.4M.
  • Monashee Investment Management added most to Viking Holdings in Q3 2024, an estimated $4.96M increase.
  • Monashee Investment Management's biggest Q3 2024 reduction was Corebridge Financial, cutting an estimated $3.86M.
  • Monashee Investment Management fully exited Birkenstock in Q3 2024, selling an estimated $10.9M.
  • Monashee Investment Management's ten largest holdings make up 69% of its $924M portfolio in Q3 2024.
  • Monashee Investment Management opened 67 new positions and closed 34 in Q3 2024.
  • Monashee Investment Management's portfolio value rose 19% quarter-over-quarter to $924M.

Based on Monashee Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.